Drug Safety and Risk Management Advisory Committee Notice of Meeting
Document ID: FDA-2012-N-0548-0086
Comments
Total: 399
-
David A Ver Helst - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0447 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Louis F. Ladson - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0448 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
American Academy of Physician Assistants - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0449 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
American Society of Consultant Pharmacists (ASCP) - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0450 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
William Edgar Hale - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0451 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Dean J Melancon - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0452 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
IRA NORMAN FREEMAN - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0453 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
James T Sajbel - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0454 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Larry E Korelc - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0455 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Arkansas Pharmacists Association - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0456 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Connie L Bolte - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0457 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
John F Ochs - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0458 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Shasta Jinkins - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0459 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Charles Ben Ellis - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0460 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Thomas Moe - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0461 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Walter Moorhead Hughes - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0462 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
John T Lipscomb - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0463 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Dan Lee Somsen - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0464 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
American Association of Nurse Practitioners (AANP) - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0465 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Russell David Lewis - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0466 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Russell David Lewis - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0467 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Elizabeth C Martin - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0468 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Ned Clark - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0469 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Joni R Cover - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0470 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Robert Anthony Pratt - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0471 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Richard Sublett Lacefield, Jr. - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0472 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Julian Ray Adams - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0473 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Parthiv Waghwala - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0474 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
DAVID ALAN PERZANOWSKI - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0475 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Mary Lou Hamill - Comment
Posted : 02/12/2013 ID ：FDA-2012-N-0548-0476 Agency : FDA -
Feb 01,2013 11:59 PM ET